Heart disease is a serious public health problem that affects millions of people worldwide. It is important to recognize the signs and symptoms of heart disease, as well as to make lifestyle changes and take medications as prescribed to reduce the risk of developing heart disease or to manage it effectively if it does occur.
A recent study by researchers from Osaka University shows that a dietary supplement, tricaprin, can help heal a broken heart. This supplement promotes lipid breakdown in heart muscle cells and has been found to significantly improve heart disease symptoms in patients with triglyceride deposit cardiomyovasculopathy (TGCV). The study shows remarkable regression of the triglyceride build-up within the blood vessels of the heart, leading to a reduction in coronary artery plaque. This new finding opens doors for a multi-faceted approach to coronary artery disease (CAD) treatment and holds promise for patients who otherwise suffer from its debilitating effects.
Ken-ichi Hirano, the lead author of the new research, explained as SciTechDaily quotes:
Almost 15 years ago we identified a new type of CAD called triglyceride deposit cardiomyovasculopathy (TGCV), in which the coronary arteries are occluded by triglyceride deposits generated by defective intracellular breakdown of triglycerides in vascular smooth muscle cells,
This mechanism makes TGCV distinct from classic cholesterol-induced atherosclerosis, and accounts for patients who are resistant to standard remedies for CAD.
The potential uses of tricaprin beyond its effect on heart health are not well established at this time. The available research on tricaprin has mainly focused on its effect on heart disease, specifically in patients with triglyceride deposit cardiomyovasculopathy (TGCV). Further research is needed to determine any additional potential benefits and uses of tricaprin. It is important to consult with a healthcare provider before using tricaprin for any purpose, as it may interact with other medications or have potential side effects.
The new study was published in European Heart Journal.
